echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Delisting of well-known pharmaceutical companies!

    Delisting of well-known pharmaceutical companies!

    • Last Update: 2021-12-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    At a time when throat diseases were high, the well-known Golden Voice suddenly announced its withdrawal from the market


    5 billion throat Chinese patent medicine market! Yangtze River, Guilin Sanjin and Golden Voice lead the way

    5 billion throat Chinese patent medicine market! Yangtze River, Guilin Sanjin and Golden Voice lead the way

    The throat is the fortress of the human body.


    As the temperature gradually drops, the weather becomes dry, and a period of high incidence of various throat diseases has come, and throat medication is about to come in handy


    According to the latest data from Mi Nei.


    Sales of proprietary Chinese medicines in terminal throats of physical pharmacies in cities in China (unit: ten thousand yuan)

    Source: Mi Nei.


    From the perspective of manufacturers, five companies, including Yangzijiang Pharmaceutical, Guilin Sanjin, Golden Throat, Guilong Pharmaceutical, and Jiangzhong Pharmaceutical, have ranked among the top 5 in recent years


    Yangzijiang Pharmaceutical leads the Chinese patent medicine market for throat, with its market share exceeding 20% ​​in 2020, and is expected to decline in 2021; Guilin Sanjin ranked second, showing an upward trend in market share; Golden Throat ranked third, with market share falling below 10%


    The market pattern of TOP5 manufacturers of Chinese patent medicines in the terminal throat of physical pharmacies in cities in China

    Source: Mi Nei.


    Throat Chinese patent medicine TOP10 exposed! 5 exclusive varieties on the list

    Throat Chinese patent medicine TOP10 exposed! 5 exclusive varieties on the list

    Top 10 Chinese patent medicine products in the terminal throat of physical pharmacies in cities in China

    Source: Mi Nei.


    In 2021, among the top 10 Chinese patent medicine products in the terminal throat of Chinese urban physical pharmacies, the sales of 10 products are expected to exceed 100 million yuan; Lanqin oral liquid is still ranked first, and sales are far ahead of other products; watermelon cream throat lozenges, The sales growth of Yinhuang Diwan is expected to exceed 20%


    Among the TOP10 products, there are 5 exclusive varieties, including Yangzijiang Pharmaceutical’s Lanqin Oral Liquid, Guangxi Golden Throat’s Golden Throat Lozenges, Guilin Sanjin Pharmaceutical’s Guilin Watermelon Cream and Watermelon Cream Lozenges, and Jiangzhong Pharmaceutical’s Compound Herb.


    Top 10 Chinese proprietary Chinese medicine brands in the terminal throat of physical pharmacies in cities in China

    Source: Mi Nei.


    In 2021, among the TOP10 brands of proprietary Chinese medicines in the terminal throat of physical pharmacies in Chinese cities, there are estimated to be 8 brands with sales of more than 100 million yuan, and the three major brands of Lanqin Oral Liquid, Golden Throat Lozenges and Guilin Watermelon Cream are firmly ranked in the top three


    From the list of companies, Guilin Sanjin has as many as 3 brands on the list, including Guilin Watermelon Cream, Watermelon Cream Lozenges and Watermelon Cream Qingyan Lozenges, all of which are watermelon frost products and are exclusive varieties; China Resources There are 2 medical brands on the list, including the compound Cao Shan Shan tablets and China Resources Sanjiu's pharyngitis tablets


    90% of the market value has evaporated, and well-known pharmaceutical companies announce their delisting

    90% of the market value has evaporated, and well-known pharmaceutical companies announce their delisting

    "Protect your throat, please use Golden Throat Lozenges, Guangxi Golden Throat


    On October 29, Golden Throat issued an announcement stating that the company will be privatized through an agreement arrangement, and shares will be cancelled at HK$2.


    One stone caused a thousand waves, why did the golden voice degenerate to the point of delisting?

    Since the 1990s, Golden Throat’s representative products Golden Throat Lozenge and Golden Throat Lozenge have created huge wealth for the company
    .
    But in the great changes of the times, the revenue structure of Golden Throat has long relied on Golden Throat Lozenges and Golden Throat Lozenges, and these two products are also facing a sales ceiling
    .

    According to data from Mi Nei.
    com, the sales of Golden Throat Throat in Chinese urban physical pharmacies have risen all the way, exceeding 400 million yuan in 2016 and 500 million yuan in 2019, and sales in 2020 will decline by nearly 15%.
    It is expected to be 2021.
    Sales also failed to exceed 500 million yuan
    .
    At the same time, the entire throat Chinese patent medicine market is also showing weakness
    .

    Sales of Golden Throat Throat in Entity Pharmacies in Chinese Cities (Unit: RMB 10,000)

    Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern

    Centralized sourcing has taught many companies that dominate in single products a profound lesson
    .
    Jiang Peizhen, the founder of Golden Throat, has already realized the risk of single product monopoly and tried to lead the company to a diversified development path
    .
    However, Golden Throat is a company that makes a fortune by marketing, and has invested very little in product research and development for a long time.
    The lack of research and development genes is doomed to failure in transformation
    .

    In the past, advertising and marketing can solve most problems by spending money
    .
    With the rapid development of the Internet, endless new products, and increased consumer awareness and demand, advertising and marketing can no longer be solved by simply spending money
    .
    Failure to keep up with the rhythm of the times has become a dilemma that Golden Voice cannot solve in the short term
    .

    The good news is that Golden Voice is delisting rather than bankrupt
    .
    Golden Voice said that the privatization is a good opportunity for shareholders to realize their investment
    .
    The company needs a clear revitalization plan, and this will require a lot of investment, which can only be achieved through privatization and the introduction of external capital from well-known investment professionals
    .
    After privatization, Golden Voice will carry out business transformation and look for opportunities for a comeback
    .

    Source: Mi Nei.
    com database, company announcement

    Note: China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 cities and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
    .
    The above sales are calculated based on the average retail price of the product at the terminal!

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.